Publications 2011

1. Jastrzebska-Wiesek, M.; Partyka, A.; Chłoń-Rzepa, G.; Wrobel, D.; Duszyńska, B.; Bojarski, A. J.; Wesołowska, A. Potential anxiolytic, but not antidepressant, activity of new 7-arylpiperazinylbutyl-8-morpholinyl-purine-2,6-dione analogs in mice. Acta Biol. Cracov. Zool. 2011, 53, 29-35
(http://czasopisma.pan.pl/images/data/abcsz/No_53_2011/5.%20Potential.pdf).
2. Handzlik, J.; Szymanska, E.; Nedza, K.; Kubacka, M.; Siwek, A.; Mogilski, S.; Handzlik, J.; Filipek, B.; Kiec-Kononowicz, K. Pharmacophore models based studies on the affinity and selectivity toward 5-HT1A with reference to alpha1-adrenergic receptors among arylpiperazine derivatives of phenytoin.  Bioorg. Med. Chem. 2011, 19, 1349-1360 (http://www.ncbi.nlm.nih.gov/pubmed/21232965).
3. Antkiewicz-Michaluk, L.; Wasik, A.; Romanska, I.; Bojarski, A.; Michaluk, J. Both stereoselective (R)- and (S)-1-Methyl-1,2,3,4-tetrahydroisoquinoline enantiomers protect striatal terminals against rotenone-induced suppression of dopamine release. Neurotox. Res. 2011, 20, 134-149 (http://www.ncbi.nlm.nih.gov/pubmed/21069490).
4. Mordalski, S.; Kosciolek, T.; Kristiansen, K.; Sylte, I.; Bojarski, A. J. Protein binding site analysis by means of structural interaction fingerprint patterns. Bioorg. Med. Chem. Lett. 2011, 21, 6816-6819 (http://www.ncbi.nlm.nih.gov/pubmed/21974955).
5. Zajdel, P.; Marciniec, K.; Maslankiewicz, A.; Paluchowska, M. H.; Satala, G.; Partyka, A.; Jastrzebska-Wiesek, M.; Wrobel, D.; Wesolowska, A.; Duszynska, B.; Bojarski, A. J.; Pawlowski, M. Arene- and quinoline-sulfonamides as novel 5-HT(7) receptor ligands. Bioorg. Med. Chem. 2011, 19, 6750-6759 (http://www.ncbi.nlm.nih.gov/pubmed/22001327).
6. Lewgowd, W.; Bojarski, A. J.; Szczesio, M.; Olczak, A.; Glowka, M. L.; Mordalski, S.; Stanczak, A. Synthesis and structural investigation of some pyrimido[5,4-c]quinolin-4(3H)-one derivatives with a long-chain arylpiperazine moiety as potent 5-HT(1A/2A) and 5-HT(7) receptor ligands. Eur. J. Med. Chem. 2011, 46, 3348-3361
(http://www.ncbi.nlm.nih.gov/pubmed/21601317).
7. Zajdel, P.; Król, J.; Grychowska, K.; Pawłowski, M.; Subra, G.; Nomezine, G.; Martinez, J.; Satała, G.; Bojarski, A. J.; Zhou, Z.; O’Donnel, M. J.; Scott, W. L. Solid-Phase Synthesis of Arylpiperazine Derivatives and Implementation of the Distributed Drug Discovery (D3) . Molecules 2011, 16, 4104-4121 (http://www.mdpi.com/1420-3049/16/5/4104).
8. Kowalski, P.; Jaśkowska, J.; Bojarski, A. J.; Duszyńska, B.; Bucki, A.; Koaczkowski, M. Evaluation of 1-Arylpiperazine Derivative of Hydroxybenzamides as 5-HT1A and 5-HT7 Serotonin Receptor Ligands: An Experimental and Molecular Modeling Approach. J. Heterocyclic Chem. 2011,  48, 192-198
(http://onlinelibrary.wiley.com/doi/10.1002/jhet.526/abstract).